Diagnostic Deserts: National Gaps in Screening and Care Infrastructure for Metabolic Dysfunction-Associated Steatotic Liver Disease
- 9 June 2026
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (11) , 2805-2808
Abstract
INTRODUCTION: The goal of this study was to identify nationwide access to transient elastography (TE), magnetic resonance elastography (MRE), and gastroenterologists. METHODS: We used public data from each test's manufacturer's website to identify the number of TE and MRE units in the United States. We used public data from the Health Resources and Services Administration to identify the number of gastroenterologists in the United States. RESULTS: Overall, 82.4% of US counties do not contain TE or MRE, and 69.2% do not contain a gastroenterologist. Two-thirds (67.4%) of US counties do not contain either elastography or a gastroenterologist. DISCUSSION: There is limited access to TE, MRE, and gastroenterologists in the United States.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK134448)
- National Center for Advancing Translational Sciences (TL1 TR002380)
This publication has 6 references indexed in Scilit:
- Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction–associated steatotic liver diseaseHepatology Communications, 2025
- Geographic Disparities in Access to Gastroenterologists in the United StatesGastroenterology, 2025
- Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020Clinical Gastroenterology and Hepatology, 2023
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver diseaseHepatology, 2023
- Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US populationHepatology, 2023
- Real-world data reveal a diagnostic gap in non-alcoholic fatty liver diseaseBMC Medicine, 2018